RESUMEN
Understanding the pharmacokinetics of prodrugs in vivo necessitates quantitative, noninvasive, and real-time monitoring of drug release, despite its difficulty. Ratiometric photoacoustic (PA) imaging, a promising deep tissue imaging technology with a unique capacity for self-calibration, can aid in solving this problem. Here, for the first time, a methylamino-substituted Aza-BODIPY (BDP-N) and the chemotherapeutic drug camptothecin (CPT) are joined via a disulfide chain to produce the molecular theranostic prodrug (BSC) for real-time tumor mapping and quantitative visualization of intratumoral drug release using ratiometric PA imaging. Intact BSC has an extremely low toxicity, with a maximum absorption at â¼720 nm; however, endogenous glutathione (GSH), which is overexpressed in tumors, will cleave the disulfide bond and liberate CPT (with full toxicity) and BDP-N. This is accompanied by a significant redshift in absorption at â¼800 nm, resulting in the PA800/PA720 ratio. In vitro, a linear relationship is successfully established between PA800/PA720 values and CPT release rates, and subsequent experiments demonstrate that this relationship can also be applied to the quantitative detection of intratumoral CPT release in vivo. Notably, the novel ratiometric strategy eliminates nonresponsive interference and amplifies the multiples of the signal response to significantly improve the imaging contrast and detection precision. Therefore, this research offers a viable alternative for the design of molecular theranostic agents for the clinical diagnosis and treatment of tumors.
Asunto(s)
Nanopartículas , Neoplasias , Técnicas Fotoacústicas , Profármacos , Humanos , Profármacos/química , Profármacos/farmacocinética , Profármacos/uso terapéutico , Liberación de Fármacos , Técnicas Fotoacústicas/métodos , Nanopartículas/química , Neoplasias/diagnóstico por imagen , Neoplasias/tratamiento farmacológico , Disulfuros/químicaRESUMEN
Increasing Investigations show that photosensitizers (PSs) which target mitochondria are useful for enhancing photodynamic therapy (PDT) efficacy. Herein, we carefully designed and synthesized four triphenylphosphonium (TPP)-modified boron dipyrromethene (BDP)-based PSs through Cu(I)-assisted "3+2" cycloaddition reaction. All of them exhibit intense red light absorption with maxima between 659 and 663â nm, considerable fluorescence emission with quantum yields of 0.16-0.23, high singlet oxygen generation efficiency ranging from 0.22 to 0.34, excellent mitochondria-targeting ability, and good biocompatibility. Upon illumination, they induce significant cancer cell death through a mitochondria-related apoptosis pathway. The IC50 values of these BDP dyes against MCF-7 cells were determined to be as low as 0.046-0.113â µM under rather low dosage of light irradiation (1.5â J â cm-2 ).
Asunto(s)
Fotoquimioterapia , Fármacos Fotosensibilizantes , Boro/metabolismo , Colorantes/metabolismo , Mitocondrias/metabolismo , Fármacos Fotosensibilizantes/farmacología , Porfobilinógeno/análogos & derivados , Oxígeno Singlete/metabolismoRESUMEN
Herein, we fabricate a multifunctional molecular prodrug BAC where the chemotherapeutical agent camptothecin (CPT) is linked with a boron dipyrromethene (BODIPY)-based photosensitizer by an azobenzene chain which is sensitive to over-expressed azoreductase in hypoxic tumor cells. This prodrug was further loaded into biodegradable monomethoxy poly(ethylene glycol)-b-poly(caprolactone) (mPEG-b-PCL) to improve its solubility and tumor accumulation. The formed BAC nanoparticles (BAC NPs) can destroy aerobic tumor cells with relatively short distance from blood vessels by photodynamic therapy (PDT) under illumination. The PDT action inevitably leads to consumption of O2, and subsequently acute hypoxia which can induce cleavage of azobenzene linkage to boost release of CPT killing the other hypoxic interior tumor cells survived from PDT. Both in vitro and in vivo studies have verified that BAC NPs possess remarkable antitumor activity by a synergistic action of PDT and chemotherapy.
Asunto(s)
Nanopartículas , Neoplasias , Fotoquimioterapia , Profármacos , Humanos , Fármacos Fotosensibilizantes/farmacología , Fármacos Fotosensibilizantes/uso terapéutico , Profármacos/farmacología , Profármacos/uso terapéutico , Neoplasias/tratamiento farmacológico , Camptotecina/uso terapéutico , Hipoxia/tratamiento farmacológico , Línea Celular TumoralRESUMEN
Hypoxia-activated prodrugs (HAPs) have drawn increasing attention for improving the antitumor effects while minimizing side effects. However, the heterogeneous distribution of the hypoxic region in tumors severely impedes the curative effect of HAPs. Additionally, most HAPs are not amenable to optical imaging, and it is difficult to precisely trace them in tissues. Herein, we carefully designed and synthesized a multifunctional therapeutic BAC prodrug by connecting the chemotherapeutic drug camptothecin (CPT) and the fluorescent photothermal agent boron dipyrromethene (BODIPY) via hypoxia-responsive azobenzene linkers. To enhance the solubility and tumor accumulation, the prepared BAC was further encapsulated into a human serum albumin (HSA)-based drug delivery system to form HSA@BAC nanoparticles. Since the CPT was caged by a BODIPY-based molecule at the active site, the BAC exhibited excellent biosafety. Importantly, the activated CPT could be quickly released from BAC and could perform chemotherapy in hypoxic cancer cells, which was ascribed to the cleavage of the azobenzene linker by overexpressed azoreductase. After irradiation with a 730 nm laser, HSA@BAC can efficiently generate hyperthermia to achieve irreversible cancer cell death by oxygen-independent photothermal therapy. Under fluorescence imaging-guided local irradiation, both in vitro and in vivo studies demonstrated that HSA@BAC exhibited superior antitumor effects with minimal side effects.
Asunto(s)
Hipertermia Inducida , Nanopartículas , Neoplasias , Profármacos , Compuestos Azo , Boro , Compuestos de Boro , Camptotecina/química , Línea Celular Tumoral , Humanos , Hipoxia , Nanopartículas/química , Neoplasias/diagnóstico por imagen , Neoplasias/tratamiento farmacológico , Fototerapia , Terapia Fototérmica , Porfobilinógeno/análogos & derivados , Profármacos/químicaRESUMEN
Combination treatments are more effective than conventional monotherapy in combating cancer. Herein, a multifunctional prodrug BDP-L-CPT was rationally engineered and prepared by the conjugation of a boron dipyrromethene (BDP)-based photosensitizer (PS) to the active site of the chemotherapeutic drug camptothecin (CPT) via a phenyl benzoate group. After modification, the cytotoxicity of CPT was locked. Moreover, the fluorescence emission at 430 nm from the CPT component in the prodrug was substantially inhibited through the intramolecular fluorescence resonance energy transfer process. The phenyl benzoate linker in BDP-L-CPT could be selectively cleaved by exogenous carboxylesterase in phosphate-buffered saline solution and endogenous carboxylesterase overexpressed in cancer cells, which was followed by self-immolation to release free CPT. The drug release process could be monitored by the turn-on of CPT fluorescence in solution and cells. Owing to the combination of site-specific chemotherapy with light-driven photodynamic therapy, the IC50 values of the prodrug BDP-L-CPT against HepG2 human hepatocellular carcinoma and HeLa human cervical carcinoma cells were lower than those of the controls, BDP-COOH and CPT. The combined antitumor effects of the prodrug BDP-L-CPT were also observed in the mice bearing H22 tumors. Furthermore, BDP-L-CPT had a more prolonged blood circulation time in mice than CPT, which is beneficial to persistent therapy. This study may provide a promising strategy for a selective combination cancer treatment by conjugating a prodrug to a PS.
Asunto(s)
Neoplasias Hepáticas , Fotoquimioterapia , Profármacos , Animales , Sitios de Unión , Camptotecina/química , Línea Celular Tumoral , Neoplasias Hepáticas/tratamiento farmacológico , Ratones , Profármacos/químicaRESUMEN
Coencapsulation of chemotherapeutic agents and photosensitizers into nanocarriers can help to achieve a combination of chemotherapy and photodynamic therapy for superior antitumor effects. However, precise on-demand drug release remains a major challenge. In addition, the loaded photosensitizers usually tend to aggregate, which can significantly weaken their fluorescent signals and photodynamic activities. To address these issues, herein, a smart nanocarrier termed as singlet oxygen-responsive nanoparticle (SOR-NP) was constructed by introducing singlet oxygen (1O2)-sensitive aminoacrylate linkers into amphiphilic mPEG-b-PCL copolymers. Boron dipyrromethene (BDP) and paclitaxel (PTX) as model therapeutic agents were coloaded into an 1O2-responsive nanocarrier for realizing light-controlled drug release and combination cancer treatment. This polymeric nanocarrier could substantially relieve the aggregation of encapsulated BDP due to the presence of a long hydrophobic chain. Therefore, the formed SOR-NPBDP/PTX nanodrug could generate bright fluorescent signals and high levels of 1O2, which could mediate cell death via PDT and rupture aminoacrylate linker simultaneously, leading to collapse of SOR-NPBDP/PTX and subsequent PTX release. The light-triggered drug release and combined anticancer effects of SOR-NPBDP/PTX were validated in HepG2 and MCF-7 cancer cells and H22 tumor-bearing mice. This study provides a promising strategy for tumor-specific drug release and selective photodynamic-chemo combination treatment.
Asunto(s)
Antineoplásicos/uso terapéutico , Portadores de Fármacos/química , Nanopartículas/química , Neoplasias/tratamiento farmacológico , Fármacos Fotosensibilizantes/uso terapéutico , Acrilatos/síntesis química , Acrilatos/química , Animales , Antineoplásicos/química , Compuestos de Boro/química , Compuestos de Boro/uso terapéutico , Línea Celular Tumoral , Portadores de Fármacos/síntesis química , Liberación de Fármacos , Femenino , Humanos , Ratones , Paclitaxel/química , Paclitaxel/uso terapéutico , Fotoquimioterapia , Fármacos Fotosensibilizantes/química , Poliésteres/síntesis química , Poliésteres/química , Polietilenglicoles/síntesis química , Polietilenglicoles/química , Pirroles/química , Pirroles/uso terapéutico , Oxígeno Singlete/metabolismoRESUMEN
Development of the drug with high therapeutic efficacy and low toxicity is crucial to cancer ablation. In this study, we have demonstrated a red light-responsive prodrug BDP-TK-CPT by connecting the chemotherapeutic agent camptothecin with a boron dipyrromethene (BDP)-based photosensitizer via a reactive oxygen species (ROS)-labile thioketal chain. Since camptothecin is modified by a BDP-based macrocycle at the active site, the formed prodrug displays an extremely low toxicity in dark. However, upon illumination by red light, it can efficiently generate ROS leading to cell death by photodynamic therapy. Meanwhile, the ROS generated can destroy thioketal group to release free camptothecin which further results in local cell death by chemotherapy. The combined antitumor effects of the prodrug have been verified in HepG2, EC109, and HeLa cancer cells and mice bearing H22 tumors. This study may provide an alternative strategy for stimuli-responsive combination treatment of tumors by conjugation of ROS-activatable prodrugs with photosensitizing agents.
Asunto(s)
Antineoplásicos/uso terapéutico , Neoplasias/tratamiento farmacológico , Fármacos Fotosensibilizantes/uso terapéutico , Profármacos/uso terapéutico , Animales , Antineoplásicos/síntesis química , Antineoplásicos/efectos de la radiación , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Terapia Combinada , Quimioterapia , Femenino , Humanos , Luz , Ratones , Necrosis/inducido químicamente , Fotoquimioterapia , Fármacos Fotosensibilizantes/síntesis química , Fármacos Fotosensibilizantes/efectos de la radiación , Profármacos/síntesis química , Profármacos/efectos de la radiación , Especies Reactivas de Oxígeno/metabolismoRESUMEN
In this paper, experimental and theoretical studies of the piezoelectric effect of two-dimensional ZnO nanostructures, including straight nanosheets (SNSs) and curved nanosheets (CNSs) are conducted. The results show that the CNSs have a great advantage in piezoelectric property over the SNSs; the maximum output current of the NG based on CNSs was measured to be about 260 nA, much higher than that generated by SNSs. For comparatively analyzing the working mechanics of both NGs, the piezopotential distribution of both CNS and SNS structures was studied using the finite element method. The simulation result that the piezopotential generated by CNSs is always much larger than that generated by SNSs in the case of lateral bending, has more advantages for piezoelectric NGs than the SNSs. This work may provide guidance for structural optimization of piezoelectric nanogenerators and designing high-performance self-powered strain sensors.
RESUMEN
Here, we have synthesized and characterized a novel activatable photosensitizer (PS) 8a in which two well-designed boron dipyrromethene (BODIPY) derivatives are utilized as the photosensitizing fluorophore and quencher respectively, which are connected by a disulfide linker via two successive Cu (Ð) catalyzed click reactions. The fluorescence emission and singlet oxygen production of 8a are suppressed via intramolecular fluorescence resonance energy transfer (FRET) from the excited BODIPY-based PS part to quencher unit, but both of them can be simultaneously switched on by cancer-related biothiol glutathione (GSH) in phosphate buffered saline (PBS) solution with 0.05% Tween 80 as a result of cleavage of disulfide. Also, 8a exhibits a bright fluorescence image and a substantial ROS production in A549 human lung adenocarcinoma, HeLa human cervical carcinoma and H22 mouse hepatoma cells having a relatively high concentration of GSH, thereby leading to a significant photocytotoxicity, with IC50 values as low as 0.44 µM, 0.67 µM and 0.48 µM, respectively. In addition, the photosensitizer can be effectively activated and imaged in H22 transplanted hepatoma tumors of mice and shows a strong inhibition on tumor growth. All these results suggest that such a GSH-responsive photosensitizer based on FRET mechanism may provide a new strategy for tumor-targeted and fluorescence imaging-guided cancer therapy.
Asunto(s)
Antineoplásicos/farmacología , Transferencia Resonante de Energía de Fluorescencia , Glutatión/química , Imagen Óptica , Fotoquimioterapia , Fármacos Fotosensibilizantes/farmacología , Animales , Antineoplásicos/síntesis química , Antineoplásicos/química , Compuestos de Boro/síntesis química , Compuestos de Boro/química , Compuestos de Boro/farmacología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Humanos , Ratones , Ratones Endogámicos , Estructura Molecular , Neoplasias Experimentales/tratamiento farmacológico , Neoplasias Experimentales/patología , Fármacos Fotosensibilizantes/síntesis química , Fármacos Fotosensibilizantes/química , Porfobilinógeno/análogos & derivados , Porfobilinógeno/síntesis química , Porfobilinógeno/química , Porfobilinógeno/farmacología , Relación Estructura-ActividadRESUMEN
In this study, we demonstrate a novel H2O2 activatable photosensitizer (compound 7) which contains a diiodo distyryl boron dipyrromethene (BODIPY) core and an arylboronate group that quenches the excited state of the BODIPY dye by photoinduced electron transfer (PET). The BODIPY-based photosensitizer is highly soluble and remains nonaggregated in dimethyl sulfoxide (DMSO) as shown by the intense and sharp Q-band absorption (707 nm). As expected, compound 7 exhibits negligible fluorescence emission and singlet oxygen generation efficiency. However, upon interaction with H2O2, both the fluorescence emission and singlet oxygen production of the photosensitizer can be restored in phosphate buffered saline (PBS) solution and PBS buffer solution containing 20% DMSO as a result of the cleavage of the arylboronate group. Due to the higher concentration of H2O2 in cancer cells, compound 7 even with low concentration is particularly sensitive to human cervical carcinoma (HeLa) cells (IC50 = 0.95 µM) but hardly damage human embryonic lung fibroblast (HELF) cells. The results above suggest that this novel BODIPY derivative is a promising candidate for fluorescence imaging-guided photodynamic cancer therapy.
Asunto(s)
Boro/química , Peróxido de Hidrógeno/química , Fotoquimioterapia , Fármacos Fotosensibilizantes/química , Porfobilinógeno/análogos & derivados , Transporte Biológico , Línea Celular , Humanos , Estructura Molecular , Fotoquímica , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/síntesis química , Porfobilinógeno/síntesis química , Porfobilinógeno/química , Especies Reactivas de Oxígeno/metabolismo , Espectrometría de FluorescenciaRESUMEN
In this work, an ultraviolet (UV) photodetector based on a ZnO nanowires (NWs) array with metal-semiconductor-metal Schottky junction structure was successfully fabricated on a flexible polyester fibre substrate by a low-temperature hydrothermal method. Subjected to a 0.2% tensile strain at -1 V, the I light and sensitivity of the as-prepared UV photodetector are lifted by 82% and 130%, respectively. Furthermore, the response speed and recovery speed are significantly raised under the same tensile strain. The working principle can be explained as that the Schottky barrier height (SBH) is effectively improved by the negative strain-induced polarization at the metal-ZnO interface which is favorable for the separation of photogenerated electron-hole pairs. This work not only provides a facile and promising means to optimize the performance of a ZnO based MSM photodetector by applying a tensile strain but also opens up the way for fabrication and integration of ZnO photodetectors on flexible polyester fiber substrates.
RESUMEN
In this paper, we demonstrate a newly designed hybridized triboelectric nanogenerator (TENG) fabric incorporating multiple working modes, which can effectively harvest ambient mechanical energy for conversion into electric power by working in a hybridization of a contact-separation mode, a sliding mode and a freestanding triboelectric layer mode. The power generation of each mode of the TENG fabric was systematically investigated and compared along different directions, under different frequencies and at different locations. Owing to the advanced structural design, the as-fabricated TENG fabric could be switched between multiple working modes according to its real working situation. High output voltage and current of about 140 V and 0.6 µA, respectively, were obtained from a larger size of TENG fabric, which could be used to light up 120 LEDs in series. Compared to the previously reported TENGs, such a hybridized TENG fabric based on hybridized modes has much better adaptability for harvesting energy (such as human walking, running, and other human motion) in different directions. This work presents the promising potential of hybridized TENG fabric for power generation and self-powered wearable devices.
RESUMEN
Nanogenerators capable of harvesting energy from environmental mechanical energy are attractive for many applications. In this paper, we present a simple, low-cost approach to convert low-frequency mechanical energy into electric power using piezoelectric ZnO nanorods grown on a common paper substrate. This energy conversion device has ultrahigh flexibility and piezoelectric sensitivity and can produce an output voltage of up to 10 mV and an output current of about 10 nA. It is demonstrated that the device's electric output behavior can be optionally changed between four types of mode simply by controlling the straining rate. Furthermore, it is also shown that the electric output can be enhanced by scaling the size of the device. This energy-harvesting technology provides a simple and cost-effective platform to capture low-frequency mechanical energy, such as body movements, for practical applications.
RESUMEN
In this study, we examined possible impacts of the Yangtze River Three Gorges Dam (TGD), the world largest hydroelectric construction, on the adjacent marine ecosystem of the East China Sea (ECS) during its initial water storage period. The TGD filled the first one-third of its storage capacity of 39 billion m3 in 10 days in June 2003, causing an abrupt reduction in the river flow into the ECS. Noticeable changes in the microbial community structure including pico-sized autotrophs, heterotrophic bacteria and microbial diversity in the estuary and the ECS were observed 2 months later. Although causes for these changes could be multiple, the sudden decrease of river runoff and an ensuing intrusion of ECS ocean currents were postulated to be among the major ones.